The New York Academy of Sciences held its kickoff last night of Scientists Without Borders. “It’s a Match.com for organizations and resources focused on helping the developing world,” said NYAS president Ellis Rubinstein.
The initiative so far consists of a just-launched wiki—and, as such, leaves a little to be desired in terms of content. But the […]

[Read more →]

The second dispatch from Marina Maher Communication’s healthcare guru Megan Svensen:
It’s the second day of the 19th Annual PRSA Health Academy meeting in Chicago and the morning has provided more valuable learnings. Ed Schipul, CEO of Schipul – The Web Marketing Company, gave a great analogy in his talk: He says joining the blogosphere […]

[Read more →]

The discussions over the next model for pharma fall all over the map, but include one central component: a conversation with consumers. How to do it? Here, Megan Svensen, executive vice president of healthcare for Marina Maher Communications, reports in from the annual Public Relations Society of America boot camp on healthcare.
I’m coming to you […]

[Read more →]

News flowing from the American College of Cardiology meeting has been dominated by Vytorin. And after the presentation analyzing results yesterday, Miller Tabak analyst Les Fundleyter says, “We’re done for the conference in terms of the important stuff. Vytorin is the story this year.”
So what is Vytorin’s story exactly? Industry watchers say they are still […]

[Read more →]

The Foundation for Managed Care Pharmacy is all grown up. The nonprofit is flourishing under its executive director, Cindy Pigg (right), who took the reigns back in 2005 after handling pharmaceutical contracting for Cigna for 17 years. She just rang me to talk about her work to retool the organization to do the research that’s […]

[Read more →]

Salmonella. Typhoid. Shigella. Such are the diseases of the developing world. A few years back, eliminating these diseases was a non-issue for pharma—without any Western market, it didn’t register as a priority. But if you’ve followed the intersection of pharma and philanthropy over the years the way we have we have (on AIDS, TB, and […]

[Read more →]

This just in: The Healthcare Businesswomen’s Association (HBA) just announced its Woman of the Year. (Better known as WOTY, for those in the inner circle.)
At this year’s luncheon, held on May 8 at the New York Hilton, HBA will hand the WOTY honor to Charlotte Sibley, senior vice president, leadership development for Shire. This […]

[Read more →]

After eight years at CCA Advertising, Mike Devlin has left to join Concentric Advertising, as head of its new pharma consumer shop.
This follows some of the general shuffling that’s taken place at CCA Advertising since inVentiv’s $65 million buyout of the company. Some report that CCA is pushing much of its consumer work under its […]

[Read more →]

If you follow any news from the HIV/AIDS market at all, no doubt you’re like us—waiting on pins and needles to hear if FDA will approve Tibotec’s non-nucleoside reverse transcriptase inhibitor, TMC125.
The drug was accepted for priority review by FDA, with a PDUFA date of today. I got tired of checking the company’s Web site […]

[Read more →]

Aren’t Pharm Exec readers lucky? Right now, we’re working on a report for our February issue that draws on a discussion by high-ranking sales executives in the industry. I don’t want to give away too much, but we put together an expert panel about the changing sales model, and there were more than a few […]

[Read more →]